drugset
drugset / Trial / NCT01459666

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

NCT01459666 ↗

Phase 4 Terminated 9 enrolled University Hospitals Cleveland Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test if the use of DysportTM (abobotulinumtoxinA) improves wound healing and scarring after Mohs surgery. Research in the laboratory as well as previous studies in humans have shown improved wound healing and scarring with the use of a similar medication called Botox. Dysport may improve wound healing and scarring by relaxing facial muscles and therefore minimizes the muscle tension and possibly the inflammation around the wound.

Timeline

Start
2011-09
Primary completion
2019-08
Completion
2019-08

Outcome

Outcome not reported

Stopped: “Investigator left institution for private practice”

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 120 iu Intramuscular

Indications

No indication recorded.